United Pharm Cash Flow-to-Debt Ratio
United Pharm cash flow-to-debt ratio. United Pharm (033270) has a Cash Flow-to-Debt Ratio of 0.19x as of June 2026, meaning its operating cash flow of ₩13.70 Billion could theoretically repay 0% of its total liabilities (₩73.64 Billion) in one year. Check 033270 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of United Pharm (2011–2025)
Cash flow-to-debt ratio of United Pharm from 2011 to 2025. Historical debt coverage capacity for United Pharm across 14 annual periods. Check 033270 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
United Pharm Cash Flow-to-Debt Ratio by Year (2011–2025)
United Pharm cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for United Pharm. For the full cash flow conversion analysis, see 033270 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | ₩51.14 Billion | ₩64.86 Billion | ▲ +99.3% |
| 2024 | 0.40x | ₩26.79 Billion | ₩67.72 Billion | ▼ -28.3% |
| 2023 | 0.55x | ₩49.77 Billion | ₩90.18 Billion | ▼ -30.7% |
| 2022 | 0.80x | ₩63.78 Billion | ₩80.03 Billion | ▲ +43.4% |
| 2021 | 0.56x | ₩44.09 Billion | ₩79.32 Billion | ▲ +15.1% |
| 2020 | 0.48x | ₩36.96 Billion | ₩76.54 Billion | ▼ -3.6% |
| 2019 | 0.50x | ₩38.15 Billion | ₩76.14 Billion | ▼ -0.1% |
| 2018 | 0.50x | ₩36.86 Billion | ₩73.47 Billion | ▲ +16.2% |
| 2017 | 0.43x | ₩27.68 Billion | ₩64.11 Billion | ▼ -18.3% |
| 2016 | 0.53x | ₩30.02 Billion | ₩56.83 Billion | ▲ +37.0% |
| 2014 | 0.39x | ₩21.31 Billion | ₩55.27 Billion | ▲ +5.9% |
| 2013 | 0.36x | ₩18.97 Billion | ₩52.10 Billion | ▼ -10.0% |
| 2012 | 0.40x | ₩21.88 Billion | ₩54.10 Billion | ▼ -16.5% |
| 2011 | 0.48x | ₩27.62 Billion | ₩57.04 Billion | — |